Defining standard of care in the developing world: The intersection of international research ethics and health systems analysis

Adnan A. Hyder, Liza Dawson

Research output: Contribution to journalArticle

Abstract

In recent years there has been intense debate regarding the level of medical care provided to 'standard care' control groups in clinical trials in developing countries, particularly when the research sponsors come from wealthier countries. The debate revolves around the issue of how to define a standard of medical care in a country in which many people are not receiving the best methods of medical care available in other settings. In this paper, we argue that additional dimensions of the standard of care have been hitherto neglected, namely, the structure and efficiency of the national health system. The health system affects locally available medical care in two important ways: first, the system may be structured to provide different levels of care at different sites with referral mechanisms to direct patients to the appropriate level of care. Second, inefficiencies in this system may influence what care is available in a particular locale. As a result of these two factors locally available care cannot be equated with a national 'standard'. A reasonable approach is to define the national standard of care as the level of care that ought to be delivered under conditions of appropriate and efficient referral in a national system. This standard is the minimum level of care that ought to be provided to a control group. There may be additional moral arguments for higher levels of care in some circumstances. This health system analysis may be helpful to researchers and ethics committees in designing and reviewing research involving standard care control groups in developing country research.

Original languageEnglish (US)
Pages (from-to)142-152
Number of pages11
JournalDeveloping World Bioethics
Volume5
Issue number2
DOIs
StatePublished - May 2005

Fingerprint

Research Ethics
systems analysis
research ethics
ethics
Standard of Care
Systems Analysis
developing countries
Health
health
Control Groups
Developing Countries
Referral and Consultation
Research
medical care
committees
Ethics Committees
clinical trials
researchers
Research Personnel
Clinical Trials

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Social Sciences(all)
  • Arts and Humanities(all)

Cite this

Defining standard of care in the developing world : The intersection of international research ethics and health systems analysis. / Hyder, Adnan A.; Dawson, Liza.

In: Developing World Bioethics, Vol. 5, No. 2, 05.2005, p. 142-152.

Research output: Contribution to journalArticle

@article{a85aef0cd7434bfb898ab81edb2f976d,
title = "Defining standard of care in the developing world: The intersection of international research ethics and health systems analysis",
abstract = "In recent years there has been intense debate regarding the level of medical care provided to 'standard care' control groups in clinical trials in developing countries, particularly when the research sponsors come from wealthier countries. The debate revolves around the issue of how to define a standard of medical care in a country in which many people are not receiving the best methods of medical care available in other settings. In this paper, we argue that additional dimensions of the standard of care have been hitherto neglected, namely, the structure and efficiency of the national health system. The health system affects locally available medical care in two important ways: first, the system may be structured to provide different levels of care at different sites with referral mechanisms to direct patients to the appropriate level of care. Second, inefficiencies in this system may influence what care is available in a particular locale. As a result of these two factors locally available care cannot be equated with a national 'standard'. A reasonable approach is to define the national standard of care as the level of care that ought to be delivered under conditions of appropriate and efficient referral in a national system. This standard is the minimum level of care that ought to be provided to a control group. There may be additional moral arguments for higher levels of care in some circumstances. This health system analysis may be helpful to researchers and ethics committees in designing and reviewing research involving standard care control groups in developing country research.",
author = "Hyder, {Adnan A.} and Liza Dawson",
year = "2005",
month = "5",
doi = "10.1111/j.1471-8847.2005.00109.x",
language = "English (US)",
volume = "5",
pages = "142--152",
journal = "Developing World Bioethics",
issn = "1471-8731",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Defining standard of care in the developing world

T2 - The intersection of international research ethics and health systems analysis

AU - Hyder, Adnan A.

AU - Dawson, Liza

PY - 2005/5

Y1 - 2005/5

N2 - In recent years there has been intense debate regarding the level of medical care provided to 'standard care' control groups in clinical trials in developing countries, particularly when the research sponsors come from wealthier countries. The debate revolves around the issue of how to define a standard of medical care in a country in which many people are not receiving the best methods of medical care available in other settings. In this paper, we argue that additional dimensions of the standard of care have been hitherto neglected, namely, the structure and efficiency of the national health system. The health system affects locally available medical care in two important ways: first, the system may be structured to provide different levels of care at different sites with referral mechanisms to direct patients to the appropriate level of care. Second, inefficiencies in this system may influence what care is available in a particular locale. As a result of these two factors locally available care cannot be equated with a national 'standard'. A reasonable approach is to define the national standard of care as the level of care that ought to be delivered under conditions of appropriate and efficient referral in a national system. This standard is the minimum level of care that ought to be provided to a control group. There may be additional moral arguments for higher levels of care in some circumstances. This health system analysis may be helpful to researchers and ethics committees in designing and reviewing research involving standard care control groups in developing country research.

AB - In recent years there has been intense debate regarding the level of medical care provided to 'standard care' control groups in clinical trials in developing countries, particularly when the research sponsors come from wealthier countries. The debate revolves around the issue of how to define a standard of medical care in a country in which many people are not receiving the best methods of medical care available in other settings. In this paper, we argue that additional dimensions of the standard of care have been hitherto neglected, namely, the structure and efficiency of the national health system. The health system affects locally available medical care in two important ways: first, the system may be structured to provide different levels of care at different sites with referral mechanisms to direct patients to the appropriate level of care. Second, inefficiencies in this system may influence what care is available in a particular locale. As a result of these two factors locally available care cannot be equated with a national 'standard'. A reasonable approach is to define the national standard of care as the level of care that ought to be delivered under conditions of appropriate and efficient referral in a national system. This standard is the minimum level of care that ought to be provided to a control group. There may be additional moral arguments for higher levels of care in some circumstances. This health system analysis may be helpful to researchers and ethics committees in designing and reviewing research involving standard care control groups in developing country research.

UR - http://www.scopus.com/inward/record.url?scp=18844380471&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18844380471&partnerID=8YFLogxK

U2 - 10.1111/j.1471-8847.2005.00109.x

DO - 10.1111/j.1471-8847.2005.00109.x

M3 - Article

C2 - 15842723

AN - SCOPUS:18844380471

VL - 5

SP - 142

EP - 152

JO - Developing World Bioethics

JF - Developing World Bioethics

SN - 1471-8731

IS - 2

ER -